Teva and Alvotech have announced a major biosimilars alliance covering five products for the US market.
Teva and Alvotech have today announced a major biosimilars deal covering five biosimilar candidates for the US market, referring to the alliance as “one of the broadest partnerships within the US biosimilar industry to date.”
The companies said the “exclusive strategic partnership” would combine “Teva’s long-standing commercial presence and extensive infrastructure in the US market...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
